Nipro Citric Complete Dry Citric Acid Concentrate recalled for high endotoxin levels
Nipro Renal Solutions USA is recalling specific lots of Citric Complete Dry Citric Acid Concentrate used in hemodialysis because they contain higher-than-safe levels of endotoxin, a bacterial substance. The affected product was distributed nationwide and internationally.
From the FDA notice · Read the official notice ↗ · All Nipro recalls
What to do
- If you use or manage hemodialysis equipment, check if you have any of the affected lot numbers (NDC5E015, NDC5E016, NDC5E017, NDC5E019, NDC5E012, NDC5B017, NDC5C023, NDC5C026, or NDC5L026).
- Contact Nipro Renal Solutions USA or your supplier for instructions on returning or replacing affected concentrate.
- Do not use concentrate from recalled lots without guidance from Nipro or your dialysis center.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 4 products — see all of them.
Details
- Units affected
- 7,770 cases
- Illnesses reported
- None reported
- Manufactured in
- 509 Fishing Creek Rd, Lewisberry, PA, United States
- Classification
- Class II
- Recall number
- Z-3135-2026
In the FDA's words
- Description
- Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25 Hemodialysis concentrates contain high endotoxin levels DCA+200-25 : Lots - NDC5E015(Exp.5/20/2027), NDC5E016(Exp.5/21/2027), NDC5E017(Exp.5/22/2027), NDC5E019(Exp.5/29/2027), NDC5E012(Exp.5/19/2027), NDC5B017(Exp.2/24/2027), NDC5C023(Exp.3/24/2027) DCA+203-25: NDC5C026(Exp.3/27/2027), NDC5L026(Exp.11/17/2027) Distribution: Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama. Affected quantity: 7,770 cases
- Hazard
- Hemodialysis concentrates contain high endotoxin levels
4 products in this recall
Nipro MedicaLyte and Citric Complete dialysis concentrates recalled for endotoxin
Nipro is recalling four hemodialysis concentrate products because they may contain high levels of endotoxin, a substance from bacteria. The recall covers about 13,000 cases and 100 drums across the US, Guatemala, and Panama, with US distribution in FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201Z-3133-2026 · 3,286 cases
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))Z-3134-2026 · 2,327 cases
- Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25 (this page)Z-3135-2026 · 7,770 cases
- Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)Z-3136-2026 · 100 drums/1072 cases